메뉴 건너뛰기




Volumn 19, Issue 5, 2013, Pages 1300-

Colon cancer mutation: Prognosis/prediction-letter

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB; FLUOROURACIL; FOLINIC ACID; OXALIPLATIN;

EID: 84874881266     PISSN: 10780432     EISSN: 15573265     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-12-3765     Document Type: Letter
Times cited : (3)

References (5)
  • 1
    • 84870339415 scopus 로고    scopus 로고
    • Mutation profiling and microsatellite instability in stage II and III colon cancer: An assessment of their prognostic and oxaliplatin predictive value
    • Gavin PG, Colangelo LH, Fumagalli D, Tanaka N, Remillard MY, Yothers G, et al. Mutation profiling and microsatellite instability in stage II and III colon cancer: an assessment of their prognostic and oxaliplatin predictive value. Clin Cancer Res 2012;18: 6531-41.
    • (2012) Clin Cancer Res , vol.18 , pp. 6531-6541
    • Gavin, P.G.1    Colangelo, L.H.2    Fumagalli, D.3    Tanaka, N.4    Remillard, M.Y.5    Yothers, G.6
  • 2
    • 77954748953 scopus 로고    scopus 로고
    • Defective mismatch repair as a predictive marker for lack of efficacy of fluorouracil-based adjuvant therapy in colon cancer
    • Sargent DJ, Marsoni S, Monges G, Thibodeau SN, Labianca R, Hamilton SR, et al. Defective mismatch repair as a predictive marker for lack of efficacy of fluorouracil-based adjuvant therapy in colon cancer. J Clin Oncol 2010;28: 3219-26.
    • (2010) J Clin Oncol , vol.28 , pp. 3219-3226
    • Sargent, D.J.1    Marsoni, S.2    Monges, G.3    Thibodeau, S.N.4    Labianca, R.5    Hamilton, S.R.6
  • 3
  • 4
    • 77951967408 scopus 로고    scopus 로고
    • Impact of p53 expression and microsatellite instability on stage III colon cancer disease-free survival in patients treated by 5-fluorouracil and leucovorin with or without oxaliplatin
    • Zaanan A, Cuilliere-Dartigues P, Guilloux A, Parc Y, Louvet C, de Gramont A, et al. Impact of p53 expression and microsatellite instability on stage III colon cancer disease-free survival in patients treated by 5-fluorouracil and leucovorin with or without oxaliplatin. Ann Oncol 2010;21: 772-80.
    • (2010) Ann Oncol , vol.21 , pp. 772-780
    • Zaanan, A.1    Cuilliere-Dartigues, P.2    Guilloux, A.3    Parc, Y.4    Louvet, C.5    De Gramont, A.6
  • 5
    • 79958828886 scopus 로고    scopus 로고
    • DNA mismatch repair status and colon cancer recurrence and survival in clinical trials of 5-fluorouracil-based adjuvant therapy
    • Sinicrope FA, Foster NR, Thibodeau SN, Marsoni S, Monges G, Labianca R, et al. DNA mismatch repair status and colon cancer recurrence and survival in clinical trials of 5-fluorouracil-based adjuvant therapy. J Natl Cancer Inst 2011;103: 863-75.
    • (2011) J Natl Cancer Inst , vol.103 , pp. 863-875
    • Sinicrope, F.A.1    Foster, N.R.2    Thibodeau, S.N.3    Marsoni, S.4    Monges, G.5    Labianca, R.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.